Pharma major Venus Remedies has received new marketing authorisations in Vietnam for its drugs Methotrexate, Cefuroxime, and ...

The phase 4, open-label AGILE trial compared the safety and efficacy of 60-, 45-, and 30-minute pegloticase infusions vs standard 120-minute protocols.

Valentine Murakatete, a 31-year-old resident of Kibagabaga, began noticing unusual itching on her skin in 2015. What started as a minor irritation soon turned into a burning sensation that spread in ...

The study showed that with each increasing year of age, the odds of receiving contraceptive counseling decreased by 5%.

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.

Electra Therapeutics has garnered the funds it needs to complete a pivotal trial of its lead drug, angling to become the ...

After the Eastern Cape Department of Health’s account with a crucial chemotherapy provider was suspended, patients were once again left at risk as the Port Elizabeth Provincial Hospital ran out of ...

Elevara’s first-in-class asset ERV001, a CDK4/6 inhibitor, is set to enter Phase II testing as an add-on treatment in RA.

A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in ...

There have been disturbing reports of substandard or falsified products causing harm to patients in a number of countries, including Kenya ...

Long-term flare risk and remission rates did not differ between patients with well-controlled RA who tapered vs continued MTX therapy.